Advisory Alpha’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Advisory Alpha’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-238	Closed	-$18K	–	306
2020 Q3	$18K	Buy	+238	New	+$17.1K	﹤0.01%	342
2020 Q2	–	Sell	-238	Closed	-$14K	–	291
2020 Q1	$14K	Sell	238 -250	-51%	-$14.5K	﹤0.01%	364
2019 Q4	$30.6K	Buy	488 +38	+8%	+$2.18K	0.01%	347
2019 Q3	$21.8K	Buy	+450	New	+$25.4K	0.01%	360

Other funds holding GNOM

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CFGS

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

Advisory Alpha's GNOM Position: Q4 2020 in Review

Advisory Alpha sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2020, closing a stake of 238 shares — an estimated $18K sold.

Advisory Alpha first reported a position in GNOM in Q3 2019 and held it in 4 quarters. The position peaked at $30.6K in Q4 2019. 26 funds tracked by Wall St. Rank hold GNOM as of Q4 2020.

Advisory Alpha reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2020 after selling out during the quarter.
Advisory Alpha sold 238 Global X Genomics & Biotechnology ETF shares in Q4 2020, an estimated $18K.
Advisory Alpha first reported a position in Global X Genomics & Biotechnology ETF in Q3 2019 and held it in 4 quarters.
Advisory Alpha's Global X Genomics & Biotechnology ETF position peaked at $30.6K in Q4 2019.
26 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2020.

Based on Advisory Alpha's 13F filing for Q4 2020, filed 16 Feb 2021.